CBUS NASDAQ
Cibus, Inc.
1W: +12.5%
1M: +9.6%
3M: +21.3%
YTD: -9.0%
1Y: +27.6%
3Y: -90.7%
5Y: -99.0%
$1.71
+0.08 (+4.91%)
Weekly Expected Move ±8.3%
$1
$2
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
11 relationships11
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2021-09-21
Earliest Filing
2025-06-06
Latest Filing
partner: 8
target: 2
acquirer: 1
Counterparties (Filed by CBUS)
11 relationshipsCompanies named in CBUS's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| A.G.P./Alliance Global Partners | — | partner | Placement agent for the public offering of Class A Common Stock. | 2025-06-06 | View |
| A.G.P./Alliance Global Partners | — | partner | Placement agent for the registered direct offering | 2025-01-22 | View |
| Cellectis S.A. | CLLS | partner | Licensee of intellectual property rights for microorganism and agricultural products | 2023-06-01 | View |
| Cellectis, Inc. | CLLS | partner | Provider of management services prior to termination | 2023-06-01 | View |
| Calyxt, Inc. | CLXT | acquirer | Parent company entering merger agreement | 2023-04-14 | View |
| Cibus Global, LLC | CBUS | target | Target company in merger agreement | 2023-04-14 | View |
| Cibus Global LLC | CBUS | target | Target company in the merger agreement with Calyxt, Inc. | 2023-01-17 | View |
| Evologic Technologies GmbH | — | partner | Manufacturing partner for Calyxt's Plant Cell Matrix platform. | 2023-01-17 | View |
| S&W Seed Company | — | partner | Licensee of Calyxt's improved digestibility alfalfa trait. | 2023-01-17 | View |
| Jefferies LLC | JEF | partner | Entered into an amended Open Market Sale Agreement to act as agent for the Company's stock offering. | 2022-10-03 | View |
| Jefferies LLC | JEF | partner | Sales agent for Calyxt, Inc.'s open market sale of common stock | 2021-09-21 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-13 | Earnings Release; Exhibits | View | |
| 2026-06-09 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-06-05 | Shareholder Vote | View | |
| 2026-04-10 | Officer/Director Change | View | |
| 2026-03-27 | Other Events; Exhibits | View | |
| 2026-03-17 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-30 | Other Events; Financial Statements and Exhibits | View | |
| 2026-01-28 | Other Events | View | |
| 2026-01-06 | Other Events | View | |
| 2025-11-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-10 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-09-23 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-09-16 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-08-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-23 | Costs Associated with Exit or Disposal Activities | View | |
| 2025-06-06 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2025-06-04 | Other Events | View | |
| 2025-05-27 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-05-23 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-08 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR